Rockwell Medical up on amended products purchase agreement

Rockwell Medical

21/09/2023 16:17

** Shares of dialysis products maker Rockwell Medical
 RMTI.O  rise 2.6% to $1.95 
    ** RMTI says it entered into an amended and restated
products purchase agreement with its largest customer, which the
company says is one of the leading providers of kidney care
services
    ** Under the agreement, RMTI and the customer agreed to an
increase in product pricing, effective Sept. 1, 2023 and
continuing until Dec. 31, 2024
    ** Pact also includes a one-time payment to Rockwell on or
after Dec. 1, 2023
    ** Product pricing will be increased in case the customer
exercises option to further extend the term through Dec. 31,
2025 
    ** Including session moves, stock up ~92% YTD

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))